Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
97.52
-0.20 (-0.20%)
Official Closing Price
Updated: 4:10 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Recap: Boston Scientific Q1 Earnings
↗
April 27, 2022
Boston Scientific (NYSE:BSX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Boston Scientific reported...
Via
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
↗
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
Via
Benzinga
Goldman Sachs And 3 Other Stocks Insiders Are Selling
↗
April 22, 2022
Although gold futures traded lower this morning on Friday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
April 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Is Boston Scientific Stock Trading Lower Premarket Today?
↗
February 02, 2022
Boston Scientific Corp (NYSE: BSX) generated
Via
Benzinga
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
↗
April 04, 2022
Health remains a tricky investment area, but Evercore analysts say there are safe bets.
Via
Investor's Business Daily
CNBC's Final Trades: Amazon, FedEx And These Health Care Picks
↗
March 20, 2022
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said that Amazon.com, Inc.
Via
Benzinga
All The Stocks That Moved Friday From CNBC's 'Fast Money: Halftime Report'
↗
March 18, 2022
CNBC's "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often move the stocks mentioned....
Via
Benzinga
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
↗
March 15, 2022
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom?
Via
Investor's Business Daily
Hopeful Golden Cross Forms On Boston Scientific's Chart
↗
March 01, 2022
If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE:BSX). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
↗
February 28, 2022
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96.
Via
Investor's Business Daily
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
↗
February 23, 2022
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
↗
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Executives Sell More Than $210M Of 5 Stocks
↗
February 09, 2022
Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades....
Via
Benzinga
What 5 Analyst Ratings Have To Say About Boston Scientific
↗
February 03, 2022
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat
↗
February 02, 2022
The company topped expectations in the fourth quarter, but guidance disappointed.
Via
Investor's Business Daily
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
↗
February 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Boston Scientific: Q4 Earnings Insights
↗
February 02, 2022
Boston Scientific (NYSE:BSX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
What Does Boston Scientific's Debt Look Like?
↗
January 28, 2022
Over the past three months, shares of Boston Scientific (NYSE:BSX) increased by 0.05%. Before we understand the importance of debt, let us look at how much debt Boston...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Earnings Scheduled For February 2, 2022
↗
February 02, 2022
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
Via
Benzinga
What Does Boston Scientific's Debt Look Like?
↗
December 15, 2021
Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
↗
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More
↗
December 09, 2021
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties.
Via
Talk Markets
Ominous Death Cross Forms On Boston Scientific's Chart
↗
December 06, 2021
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this...
Via
Benzinga
Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript
↗
October 27, 2021
BSX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
↗
October 27, 2021
Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales...
Via
Benzinga
Recap: Boston Scientific Q3 Earnings
↗
October 27, 2021
Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents
↗
October 06, 2021
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular InterVentional...
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
↗
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today